Pictured: José Baselga
Finding
By Julie Grisham, MS, Science Writer/Editor  |  Monday, April 8, 2013

Memorial Sloan-Kettering’s Physician-in-Chief, José Baselga, explains the findings from three studies on new targeted therapies for breast cancer.

Pictured: Jedd Wolchok
In the Clinic
By Media Staff  |  Thursday, April 4, 2013

Early research led by investigators at Memorial Sloan-Kettering cautions against combining ipilimumab and vemurafenib for the treatment of metastatic melanoma.

Pictured: Paul Sabbatini
Q&A
By Media Staff  |  Tuesday, April 2, 2013

In his new role as Deputy Physician-in-Chief for Clinical Research, Paul Sabbatini aims to streamline, accelerate, and expand Memorial Sloan-Kettering’s clinical research program.

Pictured: Yukio Sonoda
Video
By Memorial Sloan-Kettering  |  Wednesday, March 27, 2013

Dr. Sonoda, who performs minimally invasive procedures when possible, discusses how patients at Memorial Sloan-Kettering have the benefit of an entire team of physicians having input into their care.

Pictured: Ron Kraemer
Patient Story
By Memorial Sloan-Kettering  |  Friday, March 22, 2013

To treat his soft tissue sarcoma, 50-year-old Ron Kraemer chose Memorial Sloan-Kettering for care and support that could keep him playing music and working as a personal fitness trainer.

Pictured: Stephen Chung
Video
By Memorial Sloan-Kettering  |  Monday, March 18, 2013

Medical oncologist Dr. Chung specializes in working with patients who have leukemia and bone marrow failure syndromes, from diagnosis through treatment and general medical care.

Pictured: ESK1 Monoclonal Antibody
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, March 13, 2013

Scientists from Memorial Sloan-Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.

Pictured: Dennis Chi & Richard Barakat
Q&A
By Allyson Collins, MS, Science Writer/Editor  |  Tuesday, March 12, 2013

Gynecology Service Chief Richard Barakat comments on a recent study indicating that women treated by more-experienced physicians receive the most-appropriate care for this aggressive form of cancer.

Pictured: Raul Parra
Video
By Memorial Sloan-Kettering  |  Wednesday, March 6, 2013

Dr. Parra, who practices at Memorial Sloan-Kettering Basking Ridge, treats prostate, kidney, and bladder cancers with the goal of extending the lives of patients, and giving them the best possible quality of life.

Pictured: Massage Therapy
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Monday, March 4, 2013

Peripheral neuropathy — a nerve disorder that can cause weakness, numbness, tingling, and pain — is a common chemotherapy side effect. Treatments are available to help improve your quality of life.

Pictured: Major Trends in Modern Cancer Research Seminar
Video
By Julie Grisham, MS, Science Writer/Editor  |  Friday, March 1, 2013

At the seventh annual seminar for high school students and teachers, investigators discuss how cutting-edge biomedical research may ultimately contribute to better treatments for cancer patients.

Pictured: Martin Tallman
Video
By Memorial Sloan-Kettering  |  Wednesday, February 27, 2013

Chief of the Leukemia Service Dr. Tallman discusses how experts collaborate to deliver the most-promising therapies, and how he cares for patients as if they were members of his own family.

Pictured: David Finley & Maria Teresa Ruiz Tsukazan
Feature
By Celia Gittelson, BA  |  Monday, February 25, 2013

Our doctors introduce and apply advanced technologies in minimal-access surgery to benefit patients.

Pictured: Charles Sawyers
Honor
By Media Staff  |  Wednesday, February 20, 2013

Charles Sawyers, Chair of Memorial Sloan-Kettering’s Human Oncology and Pathogenesis Program, is a recipient of the inaugural $3 million prize for groundbreaking achievements in scientific research.

Pictured: Robin Roberts & Tonya Samuel
In the News
By Jim Stallard, MA, Writer/Editor  |  Wednesday, February 20, 2013

Co-host Robin Roberts gives thanks to her Memorial Sloan-Kettering treatment team during her first day returning to the show after receiving a stem cell transplant.

Center News

Subscribe to Our E-newsletter

Get the latest information about cancer care.